Literature DB >> 15039321

Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51.

Keita Miki1, Toshi Nagata, Takao Tanaka, Yeung-Hyen Kim, Masato Uchijima, Naoya Ohara, Satoshi Nakamura, Masaji Okada, Yukio Koide.   

Abstract

We report here the induction of specific protective cellular immunity against Mycobacterium tuberculosis by the employment of vaccination with recombinant attenuated Listeria monocytogenes strains. We constructed self-destructing attenuated L. monocytogenes Delta 2 strains carrying eukaryotic expression plasmids for the antigen 85 complex (Ag85A and Ag85B) and for MPB/MPT51 (mycobacterial protein secreted by M. bovis BCG/mycobacterial protein secreted by M. tuberculosis) molecules. Infection of these recombinant bacteria allowed expression of the genes in the J774A.1 murine macrophage cell line. Intraperitoneal vaccination of C57BL/6 mice with these recombinant bacteria was capable of inducing purified protein derivative-specific cellular immune responses, such as foot pad reactions, proliferative responses of splenocytes, and gamma interferon production from splenocytes, suggesting the efficacy of vaccination against mycobacterial infection by use of these recombinant L. monocytogenes strains. Furthermore, intravenous vaccination with recombinant bacteria carrying expression plasmids for Ag85A, Ag85B, or MPB/MPT51 in BALB/c mice elicited significant protective responses, comparable to those evoked by a live Mycobacterium bovis BCG vaccine. Notably, this is the first report to show that MPB/MPT51 is a major protective antigen in addition to Ag85A and Ag85B, which have been reported to be major mycobacterial protective antigens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039321      PMCID: PMC375201          DOI: 10.1128/IAI.72.4.2014-2021.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment.

Authors:  A Tanghe; O Denis; B Lambrecht; V Motte; T van den Berg; K Huygen
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes.

Authors:  M Lecuit; S Dramsi; C Gottardi; M Fedor-Chaiken; B Gumbiner; P Cossart
Journal:  EMBO J       Date:  1999-07-15       Impact factor: 11.598

4.  High-efficiency transformation of Listeria monocytogenes by electroporation of penicillin-treated cells.

Authors:  S F Park; G S Stewart
Journal:  Gene       Date:  1990-09-28       Impact factor: 3.688

5.  Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG.

Authors:  J Hess; L Grode; J Hellwig; P Conradt; I Gentschev; W Goebel; C Ladel; S H Kaufmann
Journal:  FEMS Immunol Med Microbiol       Date:  2000-04

6.  CD4+ T cells contain Mycobacterium tuberculosis infection in the absence of CD8+ T cells in mice vaccinated with DNA encoding Ag85A.

Authors:  S D'Souza; O Denis; T Scorza; F Nzabintwali; H Verschueren; K Huygen
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

7.  Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; T Yamada
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

8.  A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier.

Authors:  M Lecuit; S Vandormael-Pournin; J Lefort; M Huerre; P Gounon; C Dupuy; C Babinet; P Cossart
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

9.  Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A.

Authors:  S L Baldwin; C D D'Souza; I M Orme; M A Liu; K Huygen; O Denis; A Tang; L Zhu; D Montgomery; J B Ulmer
Journal:  Tuber Lung Dis       Date:  1999

10.  Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG.

Authors:  C Abou-Zeid; T L Ratliff; H G Wiker; M Harboe; J Bennedsen; G A Rook
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

View more
  27 in total

1.  Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA.

Authors:  Jin Qiu; Lin Yan; Jianbo Chen; Crystal Y Chen; Ling Shen; Norman L Letvin; Barton F Haynes; Nancy Freitag; Lijun Rong; James T Frencher; Dan Huang; Xunming Wang; Zheng W Chen
Journal:  Clin Vaccine Immunol       Date:  2011-01-26

2.  Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B.

Authors:  Hyun-Jeong Ko; Sung-Youl Ko; Yeon-Jeong Kim; Eun-Gae Lee; Sang-Nae Cho; Chang-Yuil Kang
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Pathogenicity and immunogenicity of a vaccine strain of Listeria monocytogenes that relies on a suicide plasmid to supply an essential gene product.

Authors:  Xinyan Zhao; Zhongxia Li; Baiyan Gu; Fred R Frankel
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Listeria-Vectored Vaccine Expressing the Mycobacterium tuberculosis 30-Kilodalton Major Secretory Protein via the Constitutively Active prfA* Regulon Boosts Mycobacterium bovis BCG Efficacy against Tuberculosis.

Authors:  Qingmei Jia; Barbara Jane Dillon; Saša Masleša-Galić; Marcus A Horwitz
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

5.  Vaginal protection and immunity after oral immunization of mice with a novel vaccine strain of Listeria monocytogenes expressing human immunodeficiency virus type 1 gag.

Authors:  Xinyan Zhao; Manxin Zhang; Zhongxia Li; Fred R Frankel
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.

Authors:  Avi-Hai Hovav; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

7.  Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.

Authors:  Daniela I M Loeffler; Christoph U Schoen; Werner Goebel; Sabine Pilgrim
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

8.  Analysis of the secretome and identification of novel constituents from culture filtrate of bacillus Calmette-Guerin using high-resolution mass spectrometry.

Authors:  Jianhua Zheng; Xianwen Ren; Candong Wei; Jian Yang; Yongfeng Hu; Liguo Liu; Xingye Xu; Jin Wang; Qi Jin
Journal:  Mol Cell Proteomics       Date:  2013-04-24       Impact factor: 5.911

9.  Induction of Specific CD8 T Cells against Intracellular Bacteria by CD8 T-Cell-Oriented Immunization Approaches.

Authors:  Toshi Nagata; Yukio Koide
Journal:  J Biomed Biotechnol       Date:  2010-05-24

10.  Diagnostic markers for tuberculosis ascites: a preliminary study.

Authors:  Rajpal S Kashyap; Sonali M Saha; Khushboo J Nagdev; Sanjeevani S Kelkar; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Biomark Insights       Date:  2010-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.